Retrospective Cohort Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. Dec 21, 2019; 25(47): 6835-6846
Published online Dec 21, 2019. doi: 10.3748/wjg.v25.i47.6835
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Treatment of patients with proximal esophageal cancer in the Netherlands between 1989 and 2014. A: Patients with non-metastatic proximal esophageal cancer; B: Patients with metastatic proximal esophageal cancer.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Overall survival by 5-year period of diagnosis of patients with proximal esophageal cancer in the Netherlands between 1989 and 2014, irrespective of stage at diagnosis.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Overall survival by 5-year period of diagnosis of patients with proximal esophageal cancer in the Netherlands between 1989 and 2014. A: Patients with non-metastatic proximal esophageal cancer; B: Patients with metastatic proximal esophageal cancer.
  • Citation: de Vos-Geelen J, Geurts SM, van Putten M, Valkenburg-van Iersel LB, Grabsch HI, Haj Mohammad N, Hoebers FJ, Hoge CV, Jeene PM, de Jong EJ, van Laarhoven HW, Rozema T, Slingerland M, Tjan-Heijnen VC, Nieuwenhuijzen GA, Lemmens VE. Trends in treatment and overall survival among patients with proximal esophageal cancer. World J Gastroenterol 2019; 25(47): 6835-6846
  • URL: https://www.wjgnet.com/1007-9327/full/v25/i47/6835.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v25.i47.6835